Clinical Trial Update: Guo's Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tribranch System (GENIUS Study) [NA]

View source ↗

Summary

This document provides an update on a multicenter, prospective trial evaluating the novel WeFlow-Tribranch System for aortic arch aneurysm, with status currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Arch Aneurysm

Drugs mentioned

• WeFlow-Tribranch System

Snippet

Sponsor: Hangzhou Endonom Medtech Co., Ltd. | Conditions: Aortic Arch Aneurysm | NA | Status: RECRUITING